CD24 is a promising immunotherapeutic target for enhancing efficacy of third-generation EGFR-TKIs on EGFR-mutated lung cancer.

Cancer Commun (Lond) · 2025 · PMC12629863 · PMID 41084191

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a notable trendno p-value reported

All tumors had resulted in a notable trend of shrinkage, signifying as the DTP state, which has been reported to be plastic, allowing cells to transition between dormant, senescent, stem‐like, and epithelial‐to‐mesenchymal transition (EMT) cells, which may have adaptive resistance to therapy [ 26 ].

also in 2,380 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.